11:58 AM EST - Aurinia Pharmaceuticals Inc. : Has completed the sale of 4,608,409 common shares at a weighted average price of $6.55 U.S. for aggregate gross proceeds of approximately $30 million U.S. No further sales will be conducted pursuant to the ATM. Aurinia Pharmaceuticals Inc.
shares T.AUP are trading up $0.31 at $9.50.
